S100B Protein in Serum as a Prognostic Marker for Brain Injury in Term Newborn Infants with Hypoxic Ischemic Encephalopathy - New Strategy for Early Brain Damage

Journal Title: Macedonian Journal of Medical Sciences (MJMS) - Year 2012, Vol 5, Issue 4

Abstract

Background: The aim was to investigate whether S100 in serum is a prognostic marker of cerebral injury in term newborn infants with hypoxic ischemic encephalopathy (HIE) after perinatal asphyxia. Material and Methods: All risk neonates with severe asphyxia, admitted to the neonatal and Pediatric Intensive Care Unit at the University Pediatric Hospital in Skopje-Macedonia within 24h of injury were eligible for inclusion in the study. One serum blood sample was obtained from each patient at the 24h post-injury time-point, than day 3 and day 7. S100B levels were measured using ECLIA method (ElectroChemil-Luminiscence Immuno Assay-Elecsys 2010-Roche Diagnostic). Results: One hundred and nineteen neonates were recruited. The avarage serum S100B levels for the control group (N=48) was 0.12 microgL(-1) (cut-off point). S100B levels were significantly higher in asphyxiated term neonates N=29; M= 0.64. Infants with moderate and severe HIE had significantly higher S100 levels on postnatal day 1 (p = 0.031) and day 2 (p = 0.008) than infants with mild or no HIE. Increased S100 levels were significantly inversely correlated with perinatal pH in the infants and associated with abnormal CTG at admission to the labor ward. Conclusion: Early determination of serum S100 may reflect the extent of brain damage in infants with HIE after asphyxia.

Authors and Affiliations

Aspazija Sofijanova| University Children’s Hospital, Medical Faculty, Ss Cyril and Methodius University of Skopje, Republic of Macedonia, Katica Piperkova| University Children’s Hospital, Medical Faculty, Ss Cyril and Methodius University of Skopje, Republic of Macedonia, Olivera Jordanova| University Children’s Hospital, Medical Faculty, Ss Cyril and Methodius University of Skopje, Republic of Macedonia

Keywords

Related Articles

Modern Approach to the Identification and Elimination of Periodontal Infection

In global terms, periodontitis is the leading cause of tooth loss, and causes serious aesthetic and functional problems. There are numerous scientific evidence that power periopathogenic microorganisms may have influen...

Can Statins Help„ Good Cholesterol“ to Become Even Better

Background: Ischemic heart disease IHD is a most common manifestation of generalised atherosclerosis. Hyperlipidemia is one of the most significant risk factors causing atherosclerosis. Becouse of this, statin th...

Antibiotic Resistance Patterns of Staphylococcus aureus Isolated from Nostrils of Healthy Human Subjects in a Southeastern Nigeria Locality

Background. Antibiotic resistant bacteria have been a source of ever-increasing therapeutic problem with profound health and socioeconomic pressures. Hence, continued surveillance for bacteria susceptibility pattern is...

Propionic Acidemia - Case Report With Fatal Outcome

Propionic acidemia is an inborn error of metabolism due to defective enzyme, propionyl-coenzyme A (CoA) carboxylase, which results in an accumulation of propionic acid. In this report we describe a 13 month old male in...

Lumbar Spinal Stenosis in Older Adults - Gender Differences

Background. Spinal stenosis usually occurs in older adults. The treatment of this condition is with varying success It is necessary to assess the risk and the expected benefits of the treatment (surgical or not surgica...

Download PDF file
  • EP ID EP8890
  • DOI 10.3889/MJMS.1857-5773.2012.0263
  • Views 332
  • Downloads 15

How To Cite

Aspazija Sofijanova, Katica Piperkova, Olivera Jordanova (2012). S100B Protein in Serum as a Prognostic Marker for Brain Injury in Term Newborn Infants with Hypoxic Ischemic Encephalopathy - New Strategy for Early Brain Damage. Macedonian Journal of Medical Sciences (MJMS), 5(4), 416-422. https://europub.co.uk/articles/-A-8890